Rare Disease Clinical Trials Market Size, Share & Trends Report

Rare Disease Clinical Trials Market Size, Share & Trends Analysis Report By Therapeutic Area (Autoimmune & Inflammation, Hematologic Disorders), By Phase (Phase I, Phase II), By Sponsor, By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-4-68040-031-1
Number of Pages: 225
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry: Healthcare

Market Segmentation

Rare Disease Clinical Trials Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
- Oncology
- Cardiovascular Disorders
- Neurological Disorders
- Infectious Disease
- Genetic Disorders
- Autoimmune and Inflammation
- Hematologic Disorders
- Musculoskeletal Disorders
- Others
Rare Disease Clinical Trials Phase Outlook (Revenue, USD Million, 2018 - 2030)
- Phase I
- Phase II
- Phase III
- Phase IV
Rare Disease Clinical Trials Sponsor Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceutical & Biopharmaceutical Companies
- Non-Profit Organizations
- Others
Rare Disease Clinical Trials Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Rare Disease Clinical Trials Market, By Therapeutic Area
    - Oncology
    - Cardiovascular Disorders
    - Neurological Disorders
    - Infectious Disease
    - Genetic Disorders
    - Autoimmune and Inflammation
    - Hematologic Disorders
    - Musculoskeletal Disorders
    - Others
  - North America Rare Disease Clinical Trials Market, By Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - North America Rare Disease Clinical Trials Market, By Sponsor
    - Pharmaceutical & Biopharmaceutical Companies
    - Non-Profit Organizations
    - Others
  - U.S.
    - U.S. Rare Disease Clinical Trials Market, By Therapeutic Area
      - Oncology
      - Cardiovascular Disorders
      - Neurological Disorders
      - Infectious Disease
      - Genetic Disorders
      - Autoimmune and Inflammation
      - Hematologic Disorders
      - Musculoskeletal Disorders
      - Others
    - U.S. Rare Disease Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - U.S. Rare Disease Clinical Trials Market, By Sponsor
      - Pharmaceutical & Biopharmaceutical Companies
      - Non-Profit Organizations
      - Others
  - Canada
    - Canada Rare Disease Clinical Trials Market, By Therapeutic Area
      - Oncology
      - Cardiovascular Disorders
      - Neurological Disorders
      - Infectious Disease
      - Genetic Disorders
      - Autoimmune and Inflammation
      - Hematologic Disorders
      - Musculoskeletal Disorders
      - Others
    - Canada Rare Disease Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Canada Rare Disease Clinical Trials Market, By Sponsor
      - Pharmaceutical & Biopharmaceutical Companies
      - Non-Profit Organizations
      - Others
- Europe
  - Europe Rare Disease Clinical Trials Market, By Therapeutic Area
    - Oncology
    - Cardiovascular Disorders
    - Neurological Disorders
    - Infectious Disease
    - Genetic Disorders
    - Autoimmune and Inflammation
    - Hematologic Disorders
    - Musculoskeletal Disorders
    - Others
  - Europe Rare Disease Clinical Trials Market, By Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - Europe Rare Disease Clinical Trials Market, By Sponsor
    - Pharmaceutical & Biopharmaceutical Companies
    - Non-Profit Organizations
    - Others
  - U.K.
    - U.K. Rare Disease Clinical Trials Market, By Therapeutic Area
      - Oncology
      - Cardiovascular Disorders
      - Neurological Disorders
      - Infectious Disease
      - Genetic Disorders
      - Autoimmune and Inflammation
      - Hematologic Disorders
      - Musculoskeletal Disorders
      - Others
    - U.K. Rare Disease Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - U.K. Rare Disease Clinical Trials Market, By Sponsor
      - Pharmaceutical & Biopharmaceutical Companies
      - Non-Profit Organizations
      - Others
  - Germany
    - Germany Rare Disease Clinical Trials Market, By Therapeutic Area
      - Oncology
      - Cardiovascular Disorders
      - Neurological Disorders
      - Infectious Disease
      - Genetic Disorders
      - Autoimmune and Inflammation
      - Hematologic Disorders
      - Musculoskeletal Disorders
      - Others
    - Germany Rare disease clinical trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Germany Rare disease clinical trials Market, By Sponsor
      - Pharmaceutical & Biopharmaceutical Companies
      - Non-Profit Organizations
      - Others
  - France
    - France Rare Disease Clinical Trials Market, By Therapeutic Area
      - Oncology
      - Cardiovascular Disorders
      - Neurological Disorders
      - Infectious Disease
      - Genetic Disorders
      - Autoimmune and Inflammation
      - Hematologic Disorders
      - Musculoskeletal Disorders
      - Others
    - France Rare Disease Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - France Rare Disease Clinical Trials Market, By Sponsor
      - Pharmaceutical & Biopharmaceutical Companies
      - Non-Profit Organizations
      - Others
  - Italy
    - Italy Rare Disease Clinical Trials Market, By Therapeutic Area
      - Oncology
      - Cardiovascular Disorders
      - Neurological Disorders
      - Infectious Disease
      - Genetic Disorders
      - Autoimmune and Inflammation
      - Hematologic Disorders
      - Musculoskeletal Disorders
      - Others
    - Italy Rare Disease Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Italy Rare Disease Clinical Trials Market, By Sponsor
      - Pharmaceutical & Biopharmaceutical Companies
      - Non-Profit Organizations
      - Others
  - Spain
    - Spain Rare Disease Clinical Trials Market, By Therapeutic Area
      - Oncology
      - Cardiovascular Disorders
      - Neurological Disorders
      - Infectious Disease
      - Genetic Disorders
      - Autoimmune and Inflammation
      - Hematologic Disorders
      - Musculoskeletal Disorders
      - Others
    - Spain Rare Disease Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Spain Rare Disease Clinical Trials Market, By Sponsor
      - Pharmaceutical & Biopharmaceutical Companies
      - Non-Profit Organizations
      - Others
  - Denmark
    - Denmark Rare Disease Clinical Trials Market, By Therapeutic Area
      - Oncology
      - Cardiovascular Disorders
      - Neurological Disorders
      - Infectious Disease
      - Genetic Disorders
      - Autoimmune and Inflammation
      - Hematologic Disorders
      - Musculoskeletal Disorders
      - Others
    - Denmark Rare Disease Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Denmark Rare Disease Clinical Trials Market, By Sponsor
      - Pharmaceutical & Biopharmaceutical Companies
      - Non-Profit Organizations
      - Others
  - Sweden
    - Sweden Rare Disease Clinical Trials Market, By Therapeutic Area
      - Oncology
      - Cardiovascular Disorders
      - Neurological Disorders
      - Infectious Disease
      - Genetic Disorders
      - Autoimmune and Inflammation
      - Hematologic Disorders
      - Musculoskeletal Disorders
      - Others
    - Sweden Rare Disease Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Sweden Rare Disease Clinical Trials Market, By Sponsor
      - Pharmaceutical & Biopharmaceutical Companies
      - Non-Profit Organizations
      - Others
  - Norway
    - Norway Rare Disease Clinical Trials Market, By Therapeutic Area
      - Oncology
      - Cardiovascular Disorders
      - Neurological Disorders
      - Infectious Disease
      - Genetic Disorders
      - Autoimmune and Inflammation
      - Hematologic Disorders
      - Musculoskeletal Disorders
      - Others
    - Norway Rare Disease Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Norway Rare Disease Clinical Trials Market, By Sponsor
      - Pharmaceutical & Biopharmaceutical Companies
      - Non-Profit Organizations
      - Others
- Asia Pacific
  - Asia Pacific Rare Disease Clinical Trials Market, By Therapeutic Area
    - Oncology
    - Cardiovascular Disorders
    - Neurological Disorders
    - Infectious Disease
    - Genetic Disorders
    - Autoimmune and Inflammation
    - Hematologic Disorders
    - Musculoskeletal Disorders
    - Others
  - Asia Pacific Rare Disease Clinical Trials Market, By Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - Asia Pacific Rare Disease Clinical Trials Market, By Sponsor
    - Pharmaceutical & Biopharmaceutical Companies
    - Non-Profit Organizations
    - Others
  - India
    - India Rare Disease Clinical Trials Market, By Therapeutic Area
      - Oncology
      - Cardiovascular Disorders
      - Neurological Disorders
      - Infectious Disease
      - Genetic Disorders
      - Autoimmune and Inflammation
      - Hematologic Disorders
      - Musculoskeletal Disorders
      - Others
    - India Rare Disease Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - India Rare Disease Clinical Trials Market, By Sponsor
      - Pharmaceutical & Biopharmaceutical Companies
      - Non-Profit Organizations
      - Others
  - Japan
    - Japan Rare Disease Clinical Trials Market, By Therapeutic Area
      - Oncology
      - Cardiovascular Disorders
      - Neurological Disorders
      - Infectious Disease
      - Genetic Disorders
      - Autoimmune and Inflammation
      - Hematologic Disorders
      - Musculoskeletal Disorders
      - Others
    - Japan Rare Disease Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Japan Rare Disease Clinical Trials Market, By Sponsor
      - Pharmaceutical & Biopharmaceutical Companies
      - Non-Profit Organizations
      - Others
  - China
    - China Rare Disease Clinical Trials Market, By Therapeutic Area
      - Oncology
      - Cardiovascular Disorders
      - Neurological Disorders
      - Infectious Disease
      - Genetic Disorders
      - Autoimmune and Inflammation
      - Hematologic Disorders
      - Musculoskeletal Disorders
      - Others
    - China Rare Disease Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - China Rare Disease Clinical Trials Market, By Sponsor
      - Pharmaceutical & Biopharmaceutical Companies
      - Non-Profit Organizations
      - Others
  - Australia
    - Australia Rare Disease Clinical Trials Market, By Therapeutic Area
      - Oncology
      - Cardiovascular Disorders
      - Neurological Disorders
      - Infectious Disease
      - Genetic Disorders
      - Autoimmune and Inflammation
      - Hematologic Disorders
      - Musculoskeletal Disorders
      - Others
    - Australia Rare Disease Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Australia Rare Disease Clinical Trials Market, By Sponsor
      - Pharmaceutical & Biopharmaceutical Companies
      - Non-Profit Organizations
      - Others
  - South Korea
    - South Korea Rare Disease Clinical Trials Market, By Therapeutic Area
      - Oncology
      - Cardiovascular Disorders
      - Neurological Disorders
      - Infectious Disease
      - Genetic Disorders
      - Autoimmune and Inflammation
      - Hematologic Disorders
      - Musculoskeletal Disorders
      - Others
    - South Korea Rare Disease Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - South Korea Rare Disease Clinical Trials Market, By Sponsor
      - Pharmaceutical & Biopharmaceutical Companies
      - Non-Profit Organizations
      - Others
  - Thailand
    - Thailand Rare Disease Clinical Trials Market, By Therapeutic Area
      - Oncology
      - Cardiovascular Disorders
      - Neurological Disorders
      - Infectious Disease
      - Genetic Disorders
      - Autoimmune and Inflammation
      - Hematologic Disorders
      - Musculoskeletal Disorders
      - Others
    - Thailand Rare Disease Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Thailand Rare Disease Clinical Trials Market, By Sponsor
      - Pharmaceutical & Biopharmaceutical Companies
      - Non-Profit Organizations
      - Others
- Latin America
  - Latin America Rare Disease Clinical Trials Market, By Therapeutic Area
    - Oncology
    - Cardiovascular Disorders
    - Neurological Disorders
    - Infectious Disease
    - Genetic Disorders
    - Autoimmune and Inflammation
    - Hematologic Disorders
    - Musculoskeletal Disorders
    - Others
  - Latin America Rare Disease Clinical Trials Market, By Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - Latin America Rare Disease Clinical Trials Market, By Sponsor
    - Pharmaceutical & Biopharmaceutical Companies
    - Non-Profit Organizations
    - Others
  - Brazil
    - Brazil Rare Disease Clinical Trials Market, By Therapeutic Area
      - Oncology
      - Cardiovascular Disorders
      - Neurological Disorders
      - Infectious Disease
      - Genetic Disorders
      - Autoimmune and Inflammation
      - Hematologic Disorders
      - Musculoskeletal Disorders
      - Others
    - Brazil Rare Disease Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Brazil Rare Disease Clinical Trials Market, By Sponsor
      - Pharmaceutical & Biopharmaceutical Companies
      - Non-Profit Organizations
      - Others
  - Mexico
    - Mexico Rare Disease Clinical Trials Market, By Therapeutic Area
      - Oncology
      - Cardiovascular Disorders
      - Neurological Disorders
      - Infectious Disease
      - Genetic Disorders
      - Autoimmune and Inflammation
      - Hematologic Disorders
      - Musculoskeletal Disorders
      - Others
    - Mexico Rare Disease Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Mexico Rare Disease Clinical Trials Market, By Sponsor
      - Pharmaceutical & Biopharmaceutical Companies
      - Non-Profit Organizations
      - Others
  - Argentina
    - Argentina Rare Disease Clinical Trials Market, By Therapeutic Area
      - Oncology
      - Cardiovascular Disorders
      - Neurological Disorders
      - Infectious Disease
      - Genetic Disorders
      - Autoimmune and Inflammation
      - Hematologic Disorders
      - Musculoskeletal Disorders
      - Others
    - Argentina Rare Disease Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Argentina Rare Disease Clinical Trials Market, By Sponsor
      - Pharmaceutical & Biopharmaceutical Companies
      - Non-Profit Organizations
      - Others
- Middle East & Africa
  - Middle East & Africa Rare Disease Clinical Trials Market, By Therapeutic Area
    - Oncology
    - Cardiovascular Disorders
    - Neurological Disorders
    - Infectious Disease
    - Genetic Disorders
    - Autoimmune and Inflammation
    - Hematologic Disorders
    - Musculoskeletal Disorders
    - Others
  - Middle East & Africa Rare Disease Clinical Trials Market, By Phase
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - Middle East & Africa Rare Disease Clinical Trials Market, By Sponsor
    - Pharmaceutical & Biopharmaceutical Companies
    - Non-Profit Organizations
    - Others
  - South Africa
    - South Africa Rare Disease Clinical Trials Market, By Therapeutic Area
      - Oncology
      - Cardiovascular Disorders
      - Neurological Disorders
      - Infectious Disease
      - Genetic Disorders
      - Autoimmune and Inflammation
      - Hematologic Disorders
      - Musculoskeletal Disorders
      - Others
    - South Africa Rare Disease Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - South Africa Rare Disease Clinical Trials Market, By Sponsor
      - Pharmaceutical & Biopharmaceutical Companies
      - Non-Profit Organizations
      - Others
  - Saudi Arabia
    - Saudi Arabia Rare Disease Clinical Trials Market, By Therapeutic Area
      - Oncology
      - Cardiovascular Disorders
      - Neurological Disorders
      - Infectious Disease
      - Genetic Disorders
      - Autoimmune and Inflammation
      - Hematologic Disorders
      - Musculoskeletal Disorders
      - Others
    - Saudi Arabia Rare Disease Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Saudi Arabia Rare Disease Clinical Trials Market, By Sponsor
      - Pharmaceutical & Biopharmaceutical Companies
      - Non-Profit Organizations
      - Others
  - UAE
    - UAE Rare Disease Clinical Trials Market, By Therapeutic Area
      - Oncology
      - Cardiovascular Disorders
      - Neurological Disorders
      - Infectious Disease
      - Genetic Disorders
      - Autoimmune and Inflammation
      - Hematologic Disorders
      - Musculoskeletal Disorders
      - Others
    - UAE Rare Disease Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - UAE Rare Disease Clinical Trials Market, By Sponsor
      - Pharmaceutical & Biopharmaceutical Companies
      - Non-Profit Organizations
      - Others
  - Kuwait
    - Kuwait Rare Disease Clinical Trials Market, By Therapeutic Area
      - Oncology
      - Cardiovascular Disorders
      - Neurological Disorders
      - Infectious Disease
      - Genetic Disorders
      - Autoimmune and Inflammation
      - Hematologic Disorders
      - Musculoskeletal Disorders
      - Others
    - Kuwait Rare Disease Clinical Trials Market, By Phase
      - Phase I
      - Phase II
      - Phase III
      - Phase IV
    - Kuwait Rare Disease Clinical Trials Market, By Sponsor
      - Pharmaceutical & Biopharmaceutical Companies
      - Non-Profit Organizations
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.